Programmed cell death protein 1 (PD-1), is a cell surface receptor with an important role in down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity. PD-1/PDL1 axis represents a checkpoint to control immune responses and it is often used as a mechanism of immune escaping by cancers and infectious diseases. Many data demonstrate its important role in solid tumors and report emerging evidences in lymphoproliferative disorders. In this review, we summarized the available data on the role of PD-1/PD-L1 checkpoint in lymphoproliferative diseases and the therapeutics use of monoclonal blocking antibodies.

PD-1 /PD-L1 checkpoint in hematological malignancies / Annibali, O; Crescenzi, A; Tomarchio, V; Pagano, A; Bianchi, A; Grifoni, A; Avvisati, G.. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 67:(2018), pp. 45-55. [10.1016/j.leukres.2018.01.014]

PD-1 /PD-L1 checkpoint in hematological malignancies

Crescenzi A;
2018

Abstract

Programmed cell death protein 1 (PD-1), is a cell surface receptor with an important role in down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity. PD-1/PDL1 axis represents a checkpoint to control immune responses and it is often used as a mechanism of immune escaping by cancers and infectious diseases. Many data demonstrate its important role in solid tumors and report emerging evidences in lymphoproliferative disorders. In this review, we summarized the available data on the role of PD-1/PD-L1 checkpoint in lymphoproliferative diseases and the therapeutics use of monoclonal blocking antibodies.
2018
Immunotherapy; Lymphoproliferative disorders; PD-1; PD-1/PD-L1 checkpoint; PD-L1
01 Pubblicazione su rivista::01a Articolo in rivista
PD-1 /PD-L1 checkpoint in hematological malignancies / Annibali, O; Crescenzi, A; Tomarchio, V; Pagano, A; Bianchi, A; Grifoni, A; Avvisati, G.. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 67:(2018), pp. 45-55. [10.1016/j.leukres.2018.01.014]
File allegati a questo prodotto
File Dimensione Formato  
PD1 PDL1 in hematologic malignancy 1.pdf

solo gestori archivio

Note: Annibali_PD-1 /PD-L1 checkpoint_2018
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 356.03 kB
Formato Adobe PDF
356.03 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1700009
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 35
  • ???jsp.display-item.citation.isi??? ND
social impact